Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Mar;6(3):211-9.
doi: 10.1038/nrd2220. Epub 2007 Feb 9.

A Decade of Fragment-Based Drug Design: Strategic Advances and Lessons Learned

Affiliations
Review

A Decade of Fragment-Based Drug Design: Strategic Advances and Lessons Learned

Philip J Hajduk et al. Nat Rev Drug Discov. .

Abstract

Since the early 1990s, several technological and scientific advances - such as combinatorial chemistry, high-throughput screening and the sequencing of the human genome - have been heralded as remedies to the problems facing the pharmaceutical industry. The use of these technologies in some form is now well established at most pharmaceutical companies; however, the return on investment in terms of marketed products has not met expectations. Fragment-based drug design is another tool for drug discovery that has emerged in the past decade. Here, we describe the development and evolution of fragment-based drug design, analyse the role that this approach can have in combination with other discovery technologies and highlight the impact that fragment-based methods have made in progressing new medicines into the clinic.

Similar articles

See all similar articles

Cited by 236 articles

See all "Cited by" articles

LinkOut - more resources

Feedback